PuSH - Publikationsserver des Helmholtz Zentrums München

Halama, A. ; Riesen, N. ; Hrabě de Angelis, M. ; Adamski, J.

Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: Tolls for individualized medicine.

J. Intern. Med. 274, 425-439 (2013)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUND: Metabolomics is a versatile unbiased method to search for biomarkers of human disease. In particular, one approach in cancer therapy is to promote apoptosis in tumour cells; this could be improved with specific biomarkers of apoptosis for monitoring treatment. We recently observed specific metabolic patterns in apoptotic cell lines; however, in that study, apoptosis was only induced with one pro-apoptotic agent, staurosporine. OBJECTIVE: The aim of this study was to find novel biomarkers of apoptosis by verifying our previous findings using two further pro-apoptotic agents, 5-fluorouracil and etoposide, that are commonly used in anticancer treatment. METHODS: Metabolic parameters were assessed in HepG2 and HEK293 cells using the newborn screening assay adapted for cell culture approaches, quantifying the levels of amino acids and acylcarnitines with mass spectrometry. RESULTS: We were able to identify apoptosis-specific changes in the metabolite profile. Moreover, the amino acids alanine and glutamate were both significantly up-regulated in apoptotic HepG2 and HEK293 cells irrespective of the apoptosis inducer. CONCLUSION: Our observations clearly indicate the potential of metabolomics in detecting metabolic biomarkers applicable in theranostics and for monitoring drug efficacy.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Korrespondenzautor
Schlagwörter Apoptosis; Biomarkers; Cancer; Mass spectronomy; Metabolomics; Human Colorectal-cancer; Acute Myeloid-leukemia; Targeted Metabolomics; Prostate-cancer; Breast-cancer; Alzheimers-disease; Mass-spectrometry; Tumor Progression; Systems Biology; Lung-cancer
ISSN (print) / ISBN 0954-6820
e-ISSN 1365-2796
Zeitschrift Journal of Internal Medicine
Quellenangaben Band: 274, Heft: 5, Seiten: 425-439 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort Hoboken
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Experimental Genetics (IEG)